OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
36
Results
Show all
Save search
Copy query
Show results for
Unknown
(36)
Publication Date
Release Date
2022
(6)
2021
(5)
2018
(5)
2019
(4)
2020
(3)
2015
(3)
2023
(2)
2025
(1)
2024
(1)
2017
(1)
2016
(1)
2013
(1)
2012
(1)
2011
(1)
2009
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Direct Detection and Quantification of Neoantigens.
Not available
S-EPMC6825591
|
biostudies-literature
Cite
IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine.
Not available
S-EPMC6356194
|
biostudies-literature
Cite
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands.
Not available
S-EPMC8627329
|
biostudies-literature
Cite
Supplementation with
Bifidobacterium longum
subspecies
infantis
EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.
Not available
S-EPMC8578987
|
biostudies-literature
Cite
Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial.
Not available
S-EPMC8878871
|
biostudies-literature
Cite
Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry.
Not available
S-EPMC4348618
|
biostudies-literature
Cite
Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.
Not available
S-EPMC2722774
|
biostudies-literature
Cite
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Not available
S-EPMC6545851
|
biostudies-literature
Cite
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Not available
S-EPMC8120142
|
biostudies-literature
Cite
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Not available
S-EPMC9974165
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets